VERA Vera Therapeutics

• $250K bought by 1 insider
• $436K sold by 1 insider outside a trading plan
• $7M sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Marshall Fordyce CEO
   Planned sale
   $685K 18,500 shares at $37.00 7.3% of stake
   Traded Sep 15 Filed Sep 17
   ↗
3. Marshall Fordyce CEO
   Planned sale
   $650K 18,500 shares at $35.12 7.3% of stake
   Traded Sep 2 Filed Sep 4
   ↗
4. Marshall Fordyce CEO
   Planned sale
   $2M 46,250 shares at $42.30 16% of stake
   Traded Jul 7 Filed Aug 12
   ↗
5. Marshall Fordyce CEO
   Planned sale
   $702K 18,500 shares at $37.93 7.3% of stake
   Traded Jun 23 Filed Aug 12
   ↗
6. Marshall Fordyce CEO
   Planned sale
   $680K 18,500 shares at $36.74 7.3% of stake
   Traded May 12 Filed Aug 12
   ↗
7. Marshall Fordyce CEO
   Planned sale
   $1M 22,951 shares at $44.05 8.9% of stake
   Traded Apr 14 Filed Apr 15
   ↗
8. William D. Turner Chief Regulatory Officer
   Planned sale
   $501K 10,000 shares at $50.08 31% of stake
   Traded Dec 15, 2025 Filed Dec 17, 2025
   ↗
9. Patrick G Enright Director
   Buy
   $250K 5,882 shares at $42.50 New stake
   Traded Dec 11, 2025 Filed Dec 15, 2025
   ↗
10. William D. Turner Chief Regulatory Officer
    Planned sale
    $453K 10,000 shares at $45.31 31% of stake
    Traded Dec 8, 2025 Filed Dec 10, 2025
    ↗
11. William D. Turner Chief Regulatory Officer
    Planned sale
    $400K 10,000 shares at $40.00 31% of stake
    Traded Dec 3, 2025 Filed Dec 4, 2025
    ↗
12. Joseph R Young SVP, Finance, Chief Acct Offcr
    Sale
    $436K 15,000 shares at $29.06 24% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 11 option exercises, 9 stock grants, and 8 sales to cover taxes.